Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FPRG2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,782
Award facts
- Contract value 100% obligated
- $12,782.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a direct fulfillment of pharmaceutical needs within the federal supply chain. The contract carries no set-aside designation, and performance will be executed from the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for a broad spectrum of pharmaceutical products supporting military health facilities worldwide. Alecensa, an oncology treatment, aligns with DMS Pharmaceutical Group's established role as a critical supplier of specialty medications, branded and generic prescription drugs, and biologics to Department of Defense healthcare systems. The vendor has maintained a robust portfolio of pharmaceutical contract awards with DLA since its registration in SAM.gov in 2001, consistently competing effectively as a woman-owned small business in federal procurement markets.
Quick answers
Who was awarded contract SPE2DB25FPRG2?
SPE2DB25FPRG2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 28, 2025.
How much is contract SPE2DB25FPRG2 worth?
The government has obligated $12,782 on SPE2DB25FPRG2.
Is contract SPE2DB25FPRG2 an order under another contract?
Yes. SPE2DB25FPRG2 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRG2 competed?
The extent of competition for SPE2DB25FPRG2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award